ArticleCell death & disease2021

Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level.

Xianjing Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.